19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Restoration of Serotonin Neuronal Firing Following Long-Term Administration of Bupropion but Not Paroxetine in Olfactory Bulbectomized Rats

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background:

          Olfactory bulbectomized rats generally manifest many of the neurochemical, physiological, and behavioral features of major depressive disorder in humans. Another interesting feature of this model is that it responds to chronic but not acute antidepressant treatments, including selective serotonin reuptake inhibitors. The purpose of the present study was first to characterize the firing activity of dorsal raphe serotonin neurons in olfactory bulbectomized rats and then examine the effects of 2 antidepressants, bupropion and paroxetine.

          Methods:

          Olfactory bulbectomy was performed by aspirating olfactory bulbs in anesthetized rats. Vehicle and drugs were delivered for 2 and 14 days via subcutaneously implanted minipumps. In vivo electrophysiological recordings were carried out in male anesthetized Sprague-Dawley rats.

          Results:

          Following ablation of olfactory bulbs, the firing rate of serotonin neurons was decreased by 36%, leaving those of norepinephrine and dopamine neurons unchanged. In olfactory bulbectomized rats, bupropion (30mg/kg/d) restored the firing rate of serotonin neurons to the control level following 2- and 14-day administration and also induced an increase in the tonic activation of serotonin 1A receptors; paroxetine (10mg/kg/d) did not result in a return to normal of the attenuated firing of serotonin neurons in olfactory bulbectomized rats. In the hippocampus, although at a higher dose of WAY 100635 than that required in bupropion-treated animals, paroxetine administration also resulted in an increase in the tonic activation of serotonin 1A receptors.

          Conclusions:

          The present results indicate that unlike paroxetine, bupropion administration normalized serotonin neuronal activity and increased tonic activation of the serotonin 1A receptors in hippocampus.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: not found

          Are you or aren't you? Challenges associated with physiologically identifying dopamine neurons.

          The dopamine system is involved in motivation, reward and learning, and dysfunction in this system has been implicated in several disorders, including Parkinson's disease (PD) and schizophrenia. Key progress in our understanding of its functions has come from extracellular in vivo electrophysiological recordings from midbrain dopamine neurons. Numerous studies have used a defined set of criteria to identify dopamine neurons electrophysiologically. However, a few recent studies have suggested that a minority population of non-dopamine neurons may not be readily distinguishable from dopamine neurons, raising questions as to the reliability of past findings. We provide an overview of the key findings related to this controversy and assess the criteria used for the electrophysiological identification of dopamine neurons in the substantia nigra pars compacta (SNC) and ventral tegmental area (VTA). Copyright © 2012 Elsevier Ltd. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Reduced olfactory bulb volume and olfactory sensitivity in patients with acute major depression.

            The purpose of this study was to assess olfactory function and olfactory bulb volume in patients with acute major depression in comparison to a normal population. Twenty-one patients diagnosed with acute major depressive disorder and 21 healthy controls matched by age, sex and smoking behavior participated in this study. Olfactory function was assessed in a lateralized fashion using measures of odor threshold, discrimination and identification. Olfactory bulb volumes were calculated by manual segmentation of acquired T2-weighted coronal slices according to a standardized protocol. Patients with acute major depressive disorder showed significantly lower olfactory sensitivity and smaller olfactory bulb volumes. Additionally, a significant negative correlation between olfactory bulb volume and depression scores was detected. Their results provide the first evidence, to our knowledge, of decreased olfactory bulb volume in patients with acute major depression. These results might be related to reduced neurogenesis in major depression that could be reflected also at the level of the olfactory bulb. Copyright (c) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action.

              Current antidepressants are clinically effective only after several weeks of administration. Here, we show that serotonin(4) (5-HT(4)) agonists reduce immobility in the forced swimming test, displaying an antidepressant potential. Moreover, a 3 day regimen with such compounds modifies rat brain parameters considered to be key markers of antidepressant action, but that are observed only after 2-3 week treatments with classical molecules: desensitization of 5-HT(1A) autoreceptors, increased tonus on hippocampal postsynaptic 5-HT(1A) receptors, and enhanced phosphorylation of the CREB protein and neurogenesis in the hippocampus. In contrast, a 3 day treatment with the SSRI citalopram remains devoid of any effect on these parameters. Finally, a 3 day regimen with the 5-HT(4) agonist RS 67333 was sufficient to reduce both the hyperlocomotion induced by olfactory bulbectomy and the diminution of sucrose intake consecutive to a chronic mild stress. These findings point out 5-HT(4) receptor agonists as a putative class of antidepressants with a rapid onset of action.
                Bookmark

                Author and article information

                Journal
                Int J Neuropsychopharmacol
                Int. J. Neuropsychopharmacol
                ijnp
                ijnp
                International Journal of Neuropsychopharmacology
                Oxford University Press (US )
                1461-1457
                1469-5111
                February 2015
                29 January 2015
                : 18
                : 4
                : pyu050
                Affiliations
                University of Ottawa Institute of Mental Health Research , Ottawa, ON, Canada.
                Author notes
                Correspondence: Mostafa El Mansari, PhD, University of Ottawa Institute of Mental Health Research, 1145 Carling Avenue, Ottawa, ON, Canada K1Z 7K4 ( mostafa.elmansari@ 123456theroyal.ca ).
                Article
                10.1093/ijnp/pyu050
                4360219
                25522394
                f2c28653-7350-4ab4-87cd-79829d9241e0
                © The Author 2015. Published by Oxford University Press on behalf of CINP.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 2 May 2014
                : 21 July 2014
                : 25 July 2014
                Page count
                Pages: 8
                Categories
                Research Article

                Pharmacology & Pharmaceutical medicine
                electrophysiology,serotonin,bupropion,paroxetine,olfactory bulbectomy

                Comments

                Comment on this article